JAMA: Compared with blood glucose meters, can continuous blood glucose monitoring improve the level of glycosylated hemoglobin (HbA1c) in patients with type 2 diabetes?

A study based on data from the National Health and Nutrition Survey (NHANES) from 2005 to 2012 estimated that about 30% of American type 2 diabetes patients received insulin therapy, and about two-thirds of them used basal insulin instead of basal insulin.

A study based on data from the National Health and Nutrition Survey (NHANES) from 2005 to 2012 estimated that about 30% of American type 2 diabetes patients received insulin therapy, and about two-thirds of them used basal insulin instead of basal insulin.

Pixabay.

Pixabay.

Blood glucose monitoring is an important part of diabetes management.

Real-time continuous blood glucose monitoring (CGM) is mainly applied to patients with type 1 diabetes who need insulin injections.

This randomized clinical trial was conducted in 15 centers in the United States (registered from July 30, 2018 to October 30, 2019; follow-up completed on July 7, 2020), including adults with type 2 diabetes who received diabetes care, injected daily 1-2 times long-term or medium-term basal insulin, without dietary insulin, or without non-insulin hypoglycemic drugs.

The results of the study showed that out of 175 random participants, 165 (94%) completed the trial.

Hemoglobin A1c (HbA1c): Value at 8 months

Hemoglobin A1c (HbA1c): Value at 8 months Hemoglobin A1c (HbA1c): Value at 8 months Hemoglobin A1c (HbA1c): Value at 8 months

In this randomized trial, patients with type 2 diabetes had poor blood glucose control (average glycosylated hemoglobin level of 9.

In this randomized trial, patients with type 2 diabetes had poor blood glucose control (average glycosylated hemoglobin level of 9.

References: Martens T, Beck RW, Bailey R, et al.
Effect of Continuous Glucose Monitoring on Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin :A Randomized Clinical Trial .
JAMA.
Published online June 02, 2021.
doi: 10.
1001/jama.
2021.
7444 References: Martens T, Beck RW, Bailey R, et al.
Effect of Continuous Glucose Monitoring on Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin :  A Randomized Clinical Trial .
  JAMA.
 Published online June 02 , 2021.
doi:10.
1001/jama.
2021.
7444.
Martens T, Beck RW, R & lt Bailey, et Al Effect of the Continuous Glucose Monitoring ON Glycemic Control in Patients Treated With the Type 2 Diabetes With Basal Insulin :  A Randomized Clinical Trial :  .
  JAMA.
 Published Online June 02, 2021.
DOI: 10.
1001 / jama.
2021.
7444 doi:10.
1001/jama.
2021.
7444

leave a message here